Oral health related quality of life in long-term survivors of head and neck cancer compared to a general population from the seventh Tromsø study

• Published in: BMC Oral Health
• Main Authors: Renate Andreassen, Birgitta Jönsson, Elin Hadler-Olsen
• Format: Article in Journal/Newspaper
• Language: English
• Published: BMC 2022
• Subjects: Oral health related quality of life; Oral impact on daily performances; Head and neck cancer; General population; Dentistry; RK1-715; Tromsø
• Online Access: https://doi.org/10.1186/s12903-022-02140-2; https://doaj.org/article/ff755fa23dfd4190800abeeba97c8824

Abstract Background Both the incidence and survival rate of head and neck cancer (HNC) is increasing, making quality of life of HNC survivors an important issue. Methods In this cross-sectional study we compared the oral health related quality of life (OHRQoL) of long-term HNC survivors to that of a general population cohort from the seventh survey of the Tromsø study with the Oral Impact on Daily Performances questionnaire. Comparisons were done with frequency analyses and cross tabulation. We also assessed OHRQoL’s association to sociodemographic and oral health related variables in both cohorts as well as with cancer related variables in the HNC cohort with regression analyses. Results The HNC survivors had four times the risk of reporting problems with daily performances compared with the general population cohort. The ability to eat and enjoy food was most frequently affected in both cohorts. Moderate-poor self-rated dental health and general health as well as high frequency of dental visits were significantly associated with poorer OHRQoL. To have a history of oral or pharyngeal cancer was associated with more problems than having a history of laryngeal cancer. Conclusions Our study shows that HNC treatment is associated with a strong and lasting impairment of OHRQoL, highlighting the need to find less toxic, yet effective ways to treat the disease, and to provide easy access to expert dental care at all stages of the disease to minimize morbidity. Given the widespread side effects of cancer treatment, a multidisciplinary approach might be required to improve the OHRQoL of HNC survivors.